Id3-mediated enhancement of cisplatin-induced apoptosis in a sarcoma cell line MG-63

Takashi Koyama1, Hidekazu Suzuki, Atsuhiro Imakiire

  • 1Department of Immunology, Tokyo Medical University, Shinjuku-ku, Tokyo, 160-8402, Japan.

Anticancer Research
|July 28, 2004
PubMed

Insights

cis-diamminedichloroplatinum (CDDP) resistance involves DNA repair, apoptosis, and cell cycle. Inhibitor of differentiation 3 (Id3) expression increases after CDDP exposure, enhancing CDDP-induced cell death via reactive oxygen species and caspase-3 activation.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Resistance to cis-diamminedichloroplatinum (CDDP) is a significant challenge in cancer therapy.
  • Inhibitor of differentiation (Id) proteins regulate key cellular processes including cell cycle progression, differentiation, and apoptosis.
  • Understanding the role of Id proteins in CDDP resistance is crucial for developing effective treatment strategies.

Purpose of the Study:

  • To investigate the effect of CDDP exposure on the expression of Id proteins in MG-63 sarcoma cells.
  • To determine whether ectopic expression of Id proteins influences CDDP-induced cell death.
  • To elucidate the molecular mechanisms underlying CDDP resistance and sensitivity.

Main Methods:

  • MG-63 sarcoma cells were treated with CDDP.
  • Cell growth was assessed using a WST-8 assay kit.
  • Reactive oxygen species (ROS) generation was evaluated by flow cytometry.
  • Id protein expression was analyzed using reverse transcription-polymerase chain reaction (RT-PCR).
  • Caspase-3 activation was measured to assess apoptosis.

Main Results:

  • CDDP treatment led to a transient upregulation of Id3 mRNA, but not Id2, within 1-2 hours.
  • Enforced expression of Id3 sensitized MG-63 cells to CDDP-induced growth inhibition.
  • Id3 overexpression promoted CDDP-induced cell death through increased ROS generation and caspase-3 activation.

Conclusions:

  • CDDP-induced cell death in MG-63 sarcoma cells appears to involve the Id3 protein.
  • Id3 may play a significant role in modulating cellular response to CDDP treatment.
  • Targeting Id3 could be a potential therapeutic strategy to overcome CDDP resistance in certain cancers.